{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:46:51Z","timestamp":1791820011163,"version":"4.3.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017963","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T20:57:14Z","timestamp":1301605034000},"page":"e17963","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":163,"title":["NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels"],"prefix":"10.1371","volume":"6","author":[{"given":"Roman H.","family":"Haefeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja C.","family":"Gemperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Robay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Courdier Fruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Anklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dallmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Gueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(91)90029-7","article-title":"Molecular mechanisms of quinone cytotoxicity.","volume":"80","author":"PJ O'Brien","year":"1991","journal-title":"Chem Biol Interactions"},{"key":"ref2","first-page":"2","article-title":"Contemporary issues in toxicology.","volume":"112","author":"TJ Monks","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-2797(00)00200-3","article-title":"NRH:quinone oxidoreductase2 (NQO2).","volume":"129","author":"DJ Long II","year":"2000","journal-title":"Chem Biol Interact"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1039\/B715270A","article-title":"Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.","volume":"6","author":"MA Colucci","year":"2008","journal-title":"Org Biomol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of \u03b2-lapachone cytotoxicity.","volume":"275","author":"JJ Pink","year":"2000","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1158\/0008-5472.CAN-06-4480","article-title":"In vivo role of NAD(P)H:Quinone oxidoreductase 1 in metabolic activation of mitomycin C and bone marrow cytotoxicity.","volume":"67","author":"AK Adikesavan","year":"2007","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cbi.2005.01.002","article-title":"Quinone reductase 2 substrate specificity and inhibition pharmacology.","volume":"151","author":"JA Boutin","year":"2005","journal-title":"Chem Biol Interact"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10715760290021270","article-title":"Coenzyme Q cytoprotective mechanisms for mitochondrial complex I cytopathies involves NAD(P)H: quinone oxidoreductase 1 (NQO1).","volume":"36","author":"TS Chan","year":"2002","journal-title":"Free Radic Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.01.068","article-title":"Coenzyme Q(1) depletes NAD(P)H and impairs recycling of ascorbate in astrocytes.","volume":"1078","author":"M Dragan","year":"2006","journal-title":"Brain Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0006-291X(84)91389-5","article-title":"Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition.","volume":"125","author":"M Suno","year":"1984","journal-title":"Biochem Biophys Res Comm"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1248\/bpb1978.8.1006","article-title":"Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.","volume":"8","author":"Y Sugiyama","year":"1985","journal-title":"J Pharmacobio-Dyn"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-4943(89)90010-1","article-title":"Inhibition of lipid peroxidation by idebenone in brain mitochondria in the presence of succinate.","volume":"8","author":"M Suno","year":"1989","journal-title":"Arch Gerontol Geriatr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbrc.2005.11.035","article-title":"Inhibition of glycerophosphate-dependent H<sub>2<\/sub>O<sub>2<\/sub> generation in brown fat mitochondria by idebenone.","volume":"339","author":"H Rauchov\u00e0","year":"2006","journal-title":"Biochem Biophys Res Comm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/hmg\/ddn310","article-title":"Mitochondrial abnormalities in spinal and bulbar muscular atrophy.","volume":"18","author":"S Ranganathan","year":"2009","journal-title":"Hum Molr Genet"},{"key":"ref15","first-page":"3055","article-title":"A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Human Mol.","volume":"11","author":"ML Jauslin","year":"2002","journal-title":"Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00415-009-1006-z","article-title":"Pharmacokinetic properties and metabolism of idebenone.","volume":"256","author":"K Kutz","year":"2009","journal-title":"J Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2008.11.008","article-title":"Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: a long-term follow-up study.","volume":"278","author":"K Haginoya","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.47.2.583","article-title":"Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS.","volume":"47","author":"Y Ikejiri","year":"1996","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s100720070015","article-title":"Long-term treatment with idebenone and riboflavin in a patient with MELAS.","volume":"21","author":"A Napolitano","year":"2000","journal-title":"Neurol Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1517\/14656566.9.13.2327","article-title":"Idebenone in Friedreich&apos;s Ataxia.","volume":"9","author":"C Tonon","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2007.10.008","article-title":"Antioxidant use in Friedreich ataxia.","volume":"267","author":"L Myers","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.","volume":"7","author":"A R\u00f6tig","year":"1997","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1254\/jjp.57.553","article-title":"Idebenone inhibits catecholamine secretion through its blocking action on Ca<sup>2+<\/sup> channels in cultured adrenal chromaffin cells.","volume":"57","author":"H Houchi","year":"1991","journal-title":"Jpn J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-2999(00)00701-9","article-title":"CV-2619 protects cultured astrocytes against reperfusion injury via nerve growth factor production.","volume":"406","author":"K Takuma","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10863-008-9134-1","article-title":"Modification of respiratory-chain enzyme activities in brown adipose tissue mitochondria by idebenone (hydroxydecyl-ubiquinone).","volume":"40","author":"H Rauchov\u00e1","year":"2008","journal-title":"J Bioenerg Biomembr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(99)00127-2","article-title":"Inhibitory effect of the neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes.","volume":"370","author":"G Civenni","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cellbi.2007.08.003","article-title":"Biochemical study of idebenone effect on mitochondrial metabolism of yeast.","volume":"32","author":"SP Chapela","year":"2008","journal-title":"Cell Biol Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"21295","DOI":"10.1074\/jbc.M501527200","article-title":"Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools.","volume":"280","author":"AM James","year":"2005","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/abbi.1996.0267","article-title":"The interaction of Q analogs, particularly hydroxydecyl-benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.","volume":"330","author":"M Degli Esposti","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbrc.2004.03.002","article-title":"Quinone analogues regulate mitochondrial substrate competitive oxidation.","volume":"316","author":"JJ Bri\u00e8re","year":"2004","journal-title":"Biochem Biophys Res Comm"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbabio.2008.11.003","article-title":"Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species.","volume":"1787","author":"R Fato","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1248\/cpb.36.178","article-title":"Synthesis, metabolism, and in vitro biological activities of 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (CV-2619)-related compounds.","volume":"36","author":"K Okamoto","year":"1998","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0005-2736(85)90084-7","article-title":"Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles.","volume":"817","author":"LD Mayer","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"ref34","first-page":"1815","article-title":"Tolerability and improved protective action of idebenone-loaded pegylated liposomes on ethanol-induced injury in primary cortical Astrocytes.","volume":"93","author":"D Paolino","year":"2004","journal-title":"J Pharmaceut Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/abbi.1997.0344","article-title":"Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.","volume":"347","author":"K Wu","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"ref36","first-page":"4179","article-title":"Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: A novel co-substrate-mediated antitumor prodrug therapy.","volume":"60","author":"RJ Knox","year":"2000","journal-title":"Canc Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2009.11.016","article-title":"Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.","volume":"48","author":"AS Tan","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-3002(62)90997-6","article-title":"DT Diaphorase. 1. Purification from the soluble fraction of rat-liver cytoplasm, and properties.","volume":"58","author":"L Ernster","year":"1962","journal-title":"Biochim Biophys Acta"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2337\/db08-1183","article-title":"Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.","volume":"58","author":"JH Hwang","year":"2009","journal-title":"Diabetes"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(03)00025-X","article-title":"Pulmonary arterial endothelial cells affect the redox status of coenzyme Q<sub>0<\/sub>.","volume":"34","author":"SH Audi","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.93.6.2528","article-title":"The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems.","volume":"93","author":"RE Beyer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref42","first-page":"e11897","article-title":"PLoS One","volume":"5","author":"LC Lop\u00e9z","year":"2010"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BJ20040561","article-title":"Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations.","volume":"384","author":"F Pallotti","year":"2004","journal-title":"Biochem J"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1517\/13543781003727495","article-title":"Therapeutic use of coenzyme Q<sub>10<\/sub> and coenzyme Q<sub>10<\/sub>-related compounds and formulations.","volume":"19","author":"JM Villalba","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/mol.52.2.300","article-title":"The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant.","volume":"52","author":"D Siegel","year":"1997","journal-title":"Mol Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2010.03.019","article-title":"NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.","volume":"501","author":"AT Dinkova-Kostova","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(01)03172-6","article-title":"A critical appraisal of the mitochondrial coenzyme Q pool.","volume":"509","author":"G Lenaz","year":"2001","journal-title":"FEBS Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0076-6879(67)10059-1","article-title":"DT-diaphorase.","volume":"10","author":"Ernster","year":"1967","journal-title":"Methods Enzymol"},{"key":"ref49","first-page":"2542","article-title":"An alternatively spliced form of NQO1 (DT-Diaphorase) messenger RNAi the putative quinone substrate binding site is present in human normal and tumor tissues.","volume":"55","author":"PY Gasdaska","year":"1995","journal-title":"Canc Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T15:37:41Z","timestamp":1560094661000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017963"}},"subtitle":[],"editor":[{"given":"Annalisa","family":"Pastore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017963","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]}}}